Chapter 4 – nicotine dose guidance – Great Britain
Information on testing and reporting levels of nicotine uptake when submitting a notification of intent to market e-cigarette and vape products in Great Britain.
Information on testing and reporting levels of nicotine uptake when submitting a notification of intent to market e-cigarette and vape products in Great Britain.
Good Manufacturing Practice (GMP) ensures that medicinal products are consistently produced and controlled to the quality standards appropriate to their intended use or as required for marketing authorisation.
Supply of investigational medicinal productsIMPs can be supplied from Great Britain to Northern Ireland with a pragmatic approach to applying European Union (EU) rules on importation requirements. Apart from a…
The exemption enabling pharmacists to trade medicines in certain circumstances without a WDA(H) was repealed in 2012. This guidance covers the implications when supplying licensed medicines other than directly to…
This guidance from the Medicines and Healthcare Products Regulatory Agency (MHRA) covers:qualitystaff trainingcompatibilityidentificationchannel connectionmanual cleaningchemical compatibilityprocess validationpreventative maintenanceincident reporting